Literature DB >> 2078571

Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function.

A W Hahn1, T J Resink, T Scott-Burden, J Powell, Y Dohi, F R Bühler.   

Abstract

Endothelin (ET), a peptide originally isolated from the supernatants of cultured endothelial cells, exerts a wide variety of biological effects in different tissues. Endothelial-cell-synthesized ET-1 has been proposed to act in a paracrine manner on adjacent smooth muscle cells (SMC) in vivo, with effects that include both vascular reactivity (vasodilation/vasoconstriction) and mitogenesis. This study, by the use of immunocytochemically characterized SMC (rVSMC) isolated from the aortas of spontaneously hypertensive rats, has investigated a possible autocrine role for ET in regulation of the vasculature. Although quiescent cultures of rVSMC apparently did not constitutively express prepro ET-1mRNA, ET-specific transcripts could be induced by a variety of growth factors (transforming growth factor beta [TGF-beta]; platelet-derived growth factor-AA homodimer [PDGF-A chain]) and vasoactive hormones (angiotensin II [Ang II], arginine-vasopressin, and ET-1 itself). The kinetics for prepro ET-1mRNA induction in rVSMC were characteristically rapid in onset and transient. Down-regulation of protein kinase C by 48 h pretreatment of rVSMC with phorbol ester markedly reduced the subsequent ability of rVSMC to express ET-1 transcripts and secrete ET-1 peptide in response to Ang II. Inducible prepro ET-1mRNA expression was accompanied by a cycloheximide-inhibitable release of ET-1 peptide into the medium of rVSMC. ET-1 peptide was determined by both radioreceptor- and radioimmunoassay. Stimulated rVSMC accumulated ET-1 (approximately 200 pg.10(6) cells-1 x 4 h-1) at levels that attained biological relevance (approximately 10(-10) M). Sep-pak C18 extracts of medium from stimulated rVSMC elicited contraction of isolated endothelium-denuded rat mesenteric resistance vessels, and this response was characteristically protracted and difficult to "wash out." Synthetic (porcine) ET-1 promoted the expression of transcripts for PDGF-A chain, TGF-beta, and thrombospondin in quiescent rVSMC. Such effects of ET-1 on gene expression may be relevant to the mitogenic potential of ET-1 on VSMC. Our findings imply a role for ET-1 in the control of vascular function via both paracrine and autocrine regulatory mechanisms. The expression of prepro ET-1mRNA and peptide biosynthesis by rVSMC may have both short-term (e.g., vasoconstriction) and long-term (e.g., structural remodeling) consequences. A sustained loop of autocrine stimulation by ET-1 in SMC could contribute toward the pathogenesis of vasospasm and/or atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2078571      PMCID: PMC361629          DOI: 10.1091/mbc.1.9.649

Source DB:  PubMed          Journal:  Cell Regul        ISSN: 1044-2030


  53 in total

1.  A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts.

Authors:  N Takuwa; Y Takuwa; M Yanagisawa; K Yamashita; T Masaki
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

2.  Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells.

Authors:  M S Simonson; S Wann; P Mené; G R Dubyak; M Kester; Y Nakazato; J R Sedor; M J Dunn
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

Review 3.  Post-receptor signalling pathways.

Authors:  R H Michell
Journal:  Lancet       Date:  1989-04-08       Impact factor: 79.321

Review 4.  Regulation of smooth muscle proliferative phenotype by heparinoid--matrix interactions.

Authors:  T Scott-Burden; F R Bühler
Journal:  Trends Pharmacol Sci       Date:  1988-03       Impact factor: 14.819

5.  Allelic variation in HLA-B and HLA-C sequences and the evolution of the HLA-B alleles.

Authors:  H Pohla; W Kuon; P Tabaczewski; C Doerner; E H Weiss
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

6.  Growth factor control of myoepithelial-cell differentiation in cultures of human mammary gland.

Authors:  O W Petersen; B van Deurs
Journal:  Differentiation       Date:  1988-12       Impact factor: 3.880

7.  Release of different relaxing factors by cultured porcine endothelial cells.

Authors:  C Boulanger; H Hendrickson; R R Lorenz; P M Vanhoutte
Journal:  Circ Res       Date:  1989-06       Impact factor: 17.367

8.  Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.

Authors:  A J Naftilan; R E Pratt; V J Dzau
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

9.  Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells.

Authors:  H Kurihara; M Yoshizumi; T Sugiyama; F Takaku; M Yanagisawa; T Masaki; M Hamaoki; H Kato; Y Yazaki
Journal:  Biochem Biophys Res Commun       Date:  1989-03-31       Impact factor: 3.575

10.  Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells.

Authors:  T Emori; Y Hirata; K Ohta; M Shichiri; F Marumo
Journal:  Biochem Biophys Res Commun       Date:  1989-04-14       Impact factor: 3.575

View more
  27 in total

Review 1.  Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.

Authors:  Stefano Taddei; Agostino Virdis; Lorenzo Ghiadoni; Isabella Sudano; Antonio Salvetti
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Pulmonary artery smooth muscle cell endothelin-1 expression modulates the pulmonary vascular response to chronic hypoxia.

Authors:  Francis Y Kim; Elizabeth A Barnes; Lihua Ying; Chihhsin Chen; Lori Lee; Cristina M Alvira; David N Cornfield
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-14       Impact factor: 5.464

Review 3.  Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?

Authors:  L E Spieker; G Noll; F T Ruschitzka; T F Lüscher
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

4.  Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance.

Authors:  T Münzel; A Giaid; S Kurz; D J Stewart; D G Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

Review 5.  Vasopeptidase inhibition and endothelial function in hypertension.

Authors:  L V d'Uscio; T F Lüscher
Journal:  Curr Hypertens Rep       Date:  2001-12       Impact factor: 5.369

Review 6.  The role of endothelin receptor antagonists in the treatment of chronic heart failure.

Authors:  W Kiowski; G Sütsch
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

Review 7.  Drug Treatment of Hypertension: Focus on Vascular Health.

Authors:  Alan C Cameron; Ninian N Lang; Rhian M Touyz
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

8.  Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice.

Authors:  M Barton; C C Haudenschild; L V d'Uscio; S Shaw; K Münter; T F Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

Review 9.  Role of endothelin-1 in acute lung injury.

Authors:  Alejandro P Comellas; Arturo Briva
Journal:  Transl Res       Date:  2009-03-20       Impact factor: 7.012

10.  Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes.

Authors:  H Ito; Y Hirata; S Adachi; M Tanaka; M Tsujino; A Koike; A Nogami; F Murumo; M Hiroe
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.